Celularity Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Celularity Inc. (CELU) reported Increase (Decrease) in Prepaid Expense and Other Assets of $40.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-04-30
- Celularity Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$261.00K.
- Celularity Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $348.00K, a 53.04% decline year-over-year.
- Celularity Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-06-30 was $204.00K.
- Celularity Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-03-31 was -$251.00K.
- Celularity Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $40.00K.
- Celularity Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$905.00K.
- Celularity Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$5.61M.
- Celularity Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$49.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$261.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | $87.00K derived: sum of 2 quarters · filed 2026-04-30 | $291.00K derived: sum of 3 quarters · filed 2026-04-30 | $40.00K 10-K · filed 2026-04-30 | |||
| 2025-09-30 | $348.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $552.00K derived: sum of 2 quarters · filed 2025-11-14 | $301.00K 10-Q · filed 2025-11-14 | -$495.00K derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2025-06-30 | $204.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-29 | -$47.00K 10-Q · filed 2025-08-29 | -$843.00K derived: sum of 3 quarters · filed 2026-04-30 | -$102.00K derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2025-03-31 | -$251.00K 10-Q · filed 2025-08-29 | -$1.05M derived: sum of 2 quarters · filed 2026-04-30 | -$306.00K derived: sum of 3 quarters · filed 2026-04-30 | -$862.00K derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | -$796.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | -$55.00K derived: sum of 2 quarters · filed 2026-04-30 | -$611.00K derived: sum of 3 quarters · filed 2026-04-30 | -$905.00K 10-K · filed 2026-04-30 | |||
| 2024-09-30 | $741.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $185.00K derived: sum of 2 quarters · filed 2025-11-14 | -$109.00K 10-Q · filed 2025-11-14 | -$3.54M derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | -$556.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-29 | -$850.00K 10-Q · filed 2025-08-29 | -$4.28M derived: sum of 3 quarters · filed 2025-08-29 | -$3.48M derived: sum of 4 quarters · filed 2025-08-29 | |||
| 2024-03-31 | -$294.00K 10-Q · filed 2025-08-29 | -$3.72M derived: sum of 2 quarters · filed 2025-08-29 | -$2.92M derived: sum of 3 quarters · filed 2025-08-29 | -$4.44M derived: sum of 4 quarters · filed 2025-08-29 | |||
| 2023-12-31 | -$3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-08 | -$2.63M derived: sum of 2 quarters · filed 2025-05-08 | -$4.14M derived: sum of 3 quarters · filed 2025-05-08 | -$5.61M 10-K · filed 2025-05-08 | |||
| 2023-09-30 | $802.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-06 | -$716.00K derived: sum of 2 quarters · filed 2024-12-06 | -$2.18M 10-Q · filed 2024-12-06 | -$1.72M derived: sum of 4 quarters · filed 2024-12-06 | |||
| 2023-06-30 | -$1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | -$2.98M 10-Q · filed 2024-11-07 | -$2.52M derived: sum of 3 quarters · filed 2024-11-07 | -$2.52M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-03-31 | -$1.46M 10-Q · filed 2024-10-16 | -$1.00M derived: sum of 2 quarters · filed 2024-10-16 | -$1.00M derived: sum of 3 quarters · filed 2024-10-16 | -$1.86M derived: sum of 4 quarters · filed 2024-10-16 | |||
| 2022-12-31 | $461.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $462.00K derived: sum of 2 quarters · filed 2024-07-30 | -$397.00K derived: sum of 3 quarters · filed 2024-07-30 | -$49.00K 10-K · filed 2024-07-30 | |||
| 2022-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-03 | -$858.00K derived: sum of 2 quarters · filed 2024-01-03 | -$510.00K 10-Q · filed 2024-01-03 | -$5.10M derived: sum of 4 quarters · filed 2024-01-03 | |||
| 2022-06-30 | -$859.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$511.00K 10-Q · filed 2023-08-14 | -$5.10M derived: sum of 3 quarters · filed 2023-08-14 | -$5.43M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $348.00K 10-Q · filed 2023-05-22 | -$4.24M derived: sum of 2 quarters · filed 2023-05-22 | -$4.57M derived: sum of 3 quarters · filed 2023-05-22 | -$3.50M derived: sum of 4 quarters · filed 2023-05-22 | |||
| 2021-12-31 | -$4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$4.92M derived: sum of 2 quarters · filed 2023-03-31 | -$3.85M derived: sum of 3 quarters · filed 2023-03-31 | -$3.07M 10-K · filed 2023-03-31 | |||
| 2021-09-30 | -$329.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $742.00K derived: sum of 2 quarters · filed 2022-11-10 | $1.52M 10-Q · filed 2022-11-10 | $1.95M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.85M 10-Q · filed 2022-08-09 | $17.10K 10-Q · filed 2021-08-19 | $2.28M derived: sum of 3 quarters · filed 2022-08-09 | $7.61M derived: sum of 4 quarters · filed 2022-08-09 | ||
| 2021-03-31 | $780.00K 10-Q · filed 2022-05-16 | $26.25K 10-Q · filed 2021-05-24 | $1.21M derived: sum of 2 quarters · filed 2022-05-16 | $6.53M derived: sum of 3 quarters · filed 2022-05-16 | $6.51M derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $425.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $5.75M derived: sum of 2 quarters · filed 2022-03-31 | $5.73M derived: sum of 3 quarters · filed 2022-03-31 | $5.76M 10-K · filed 2022-03-31 | -$57.94K 10-K · filed 2021-03-04 | ||
| 2020-09-30 | $5.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $5.31M derived: sum of 2 quarters · filed 2021-11-12 | $5.34M 10-Q · filed 2021-11-12 | ||||
| 2020-06-30 | -$20.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-19 | $6.10K 10-Q · filed 2021-08-19 | |||||
| 2020-03-31 | $26.83K 10-Q · filed 2021-05-24 | ||||||
| 2019-12-31 | $92.15K 10-K/A · filed 2021-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |